Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case

See also
Status	Clinical Trial	Phase
Terminated	`NCT02764151` - First in Patient Study for PF-06840003 in Malignant Gliomas	Phase 1
Completed	`NCT02526017` - Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers	Phase 1
Completed	`NCT00953121` - Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG)	Phase 2
Completed	`NCT00766467` - A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas	Phase 2
Active, not recruiting	`NCT03233204` - Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)	Phase 2
Recruiting	`NCT05045027` - Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma	Early Phase 1
Completed	`NCT02507583` - Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma	Phase 1
Completed	`NCT04109209` - Psychological Intervention For Brain Tumor Caregivers	N/A
Recruiting	`NCT04937413` - The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation	Early Phase 1
Completed	`NCT03615404` - Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma	Phase 1
Active, not recruiting	`NCT04175301` - Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.	Phase 2
Terminated	`NCT02659800` - Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas	Phase 1
Active, not recruiting	`NCT02323880` - Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas	Phase 1
Completed	`NCT00782756` - Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma	Phase 2
Terminated	`NCT02855086` - Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery	Phase 1/Phase 2
Completed	`NCT02861222` - Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma	Phase 1
Completed	`NCT00634231` - A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors	Phase 1
Completed	`NCT01792505` - Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma	Phase 1
Completed	`NCT00190723` - A Study of LY317615 in Patients With Brain Tumors	Phase 2
Recruiting	`NCT04323046` - Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults	Phase 1

NCT number	NCT02300532
Study type	Observational
Source	Eisai Inc.
Contact
Status	Completed
Phase	N/A
Start date	January 10, 2013
Completion date	March 24, 2015

Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms